INO logo

INO
Inovio Pharmaceuticals Inc

92,289
Mkt Cap
$118.86M
Volume
965,124.00
52W High
$2.98
52W Low
$1.30
PE Ratio
-0.67
INO Fundamentals
Price
$1.73
Prev Close
$1.72
Open
$1.68
50D MA
$1.79
Beta
1.27
Avg. Volume
1.5M
EPS (Annual)
-$3.95
P/B
-12.00
Rev/Employee
$1,625.05
$32.54
Loading...
Loading...
News
all
press releases
INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit
INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit PR Newswire...
PR Newswire·17h ago
News Placeholder
More News
News Placeholder
Deadline Alert: Inovio Pharmaceuticals, Inc. (INO) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming April 7, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise...
Business Wire·2d ago
News Placeholder
INO SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals (INO) Investors of Securities Class Action Deadline on April 7, 2026
INO SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals (INO) Investors of Securities Class Action Deadline on April 7, 2026 INO SHAREHOLDER ACTION REMINDER: Faruqi...
PR Newswire·2d ago
News Placeholder
Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - INO
Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - INO Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the...
PR Newswire·2d ago
News Placeholder
INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm
INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities...
PR Newswire·2d ago
News Placeholder
Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc. and Certain Officers - INO
Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc. and Certain Officers - INO Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio...
PR Newswire·3d ago
News Placeholder
Deadline Approaching: Inovio Pharmaceuticals, Inc. (INO) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith
Law Offices of Howard G. Smith reminds investors of the upcoming April 7, 2026 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Inovio Pharmaceuticals...
Business Wire·3d ago
News Placeholder
Class Action Filed Against Inovio Pharmaceuticals, Inc. (INO) - April 7, 2026 Deadline to Join - Contact The Gross Law Firm
Class Action Filed Against Inovio Pharmaceuticals, Inc. (INO) - April 7, 2026 Deadline to Join - Contact The Gross Law Firm Class Action Filed Against Inovio Pharmaceuticals, Inc. (INO) - April 7...
PR Newswire·3d ago
News Placeholder
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Receives Average Recommendation of "Hold" from Brokerages
Inovio Pharmaceuticals, Inc. (NASDAQ:INO - Get Free Report) has received a consensus recommendation of "Hold" from the eight brokerages that are currently covering the stock, Marketbeat Ratings...
MarketBeat·3d ago
News Placeholder
Law Offices of Frank R. Cruz Encourages Inovio Pharmaceuticals, Inc. (INO) Shareholders To Inquire About Securities Fraud Class Action
The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of shareholders who purchased or otherwise acquired Inovio Pharmaceuticals, Inc. (Inovio or the...
Business Wire·4d ago
<
1
2
...
>

Latest INO News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.